Market Data 
Markets
Replies to post #225770 on Biotech Values
08/08/19 4:23 PM
Nektar is hosting a conference call with analysts and investors today on which it will discuss quarterly results. On the call, the company will provide a specific update and discussion on its bempegaldesleukin clinical development program, including recent developments related to the manufacturing of bempegaldesleukin.
AI
